You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • AB1090 Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of TOCILIZUMAB in Selected Italian Rheumatology Centers

Citation Tools

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Epidemiology, health services and outcome research
AB1090 Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of TOCILIZUMAB in Selected Italian Rheumatology Centers

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Tomic R, Adami S, Viapiana O, et al
AB1090 Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of TOCILIZUMAB in Selected Italian Rheumatology Centers
Annals of the Rheumatic Diseases 2014;73:1162.